Get started
Author

Baozhong Li

Observed name: B Li
ORCID: 0009-0004-6325-3475
Observed ORCID: 0009-0004-6325-3475
OpenAlex ID: A5121832828
Enhanced growth suppression of Philadephia1 leukemia cells by targeting bcr3/abl2 and VEGF through antisense strategy
2005 · X L Cong, B Li, et al. · Leukemia · 12
In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2025 · Feven Tameire, Paulina Wojnarowicz, et al. · Molecular Cancer Therapeutics · 3
Noninvasive detection of early gastric cancer via red blood cell DNA features associated with tumor-induced hematopoietic stress.
2026 · Xingyun Yao, Haobo Sun, et al. · Journal of Clinical Oncology
Non-invasive early detection of gastric cancer using red blood cell DNA genomic signature: A multi-center validation study.
2026 · Haobo Sun, Xingyun Yao, et al. · Journal of Clinical Oncology
Supplementary Figure S5 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Figure S9 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Figure S17 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Figure S1 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Table S1 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Table S2 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Figure S16 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Figure S13 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Table S5 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Figure S12 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Figure S10 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Methods from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Figure S14 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Figure S15 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Figure S2 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Table S3 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Figure S11 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Table S4 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Data from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Figure S4 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Supplementary Figure S8 from In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation
2026 · Feven Tameire, Paulina Wojnarowicz, et al.
Works count: 28
Citation count: 15
H-index: 2
I10-index: 1
Year
Topic
Type